The race to deliver the jab to the world\u2019s populations has so far been led by a handful of smaller nations, and now they\u2019re outpacing some of the wealthiest countries in the eyes of traders too.<\/p>\n
The fastest Covid-19 vaccination rollouts globally, in Israel and the United Arab Emirates, are propelling their equities to the top of the world in 2021. Israel\u2019s benchmark TA-35 stock index has gained 7.6% this year, outperforming both the S&P 500 and the Euro Stoxx Index. And the Dubai Financial Market General Index has climbed about 9.8%, all but reversing its 10% slump in 2020.<\/p>\n
Traders are rushing to price the global vaccine rollout and betting nations at the forefront will be the fastest to recover from the crisis, lifting their stocks, currencies and bond yields. The share of a country\u2019s population that has been inoculated might be \u201cthe most important statistic to track over the next year,\u201d according to strategists at JPMorgan Chase & Co.<\/p>\n
So far, Israel has vaccinated about 30% of its population and the UAE about 20%. If sustained, they could reach the threshold for herd immunity by mid-year, JPMorgan says.<\/p>\n
\u201cWill enough divergence open up with respect to herd immunity across countries to render this issue tradeable across markets? Probably,\u201d strategists led by John Normand wrote in a Jan. 8 note. \u201cThose countries that return to pre-crisis levels of activity most quickly due to some combination of stimulus and vaccine distribution should witness the most upward pressure on their interest rates and currencies.\u201d<\/p>\n
While Israel and Dubai are tantalizing examples, the case for growth fueled by vaccinations in larger economies is murky, according to Michael Herzum, who runs macro strategies at Union Investment in Frankfurt.<\/p>\n
\u201cIt is difficult to isolate these effects from other market drivers and therefore makes it difficult to play it on a country-by-country level,\u201d Herzum said. Even so, he\u2019s building vaccination rates into his cross-asset allocation decisions.<\/p>\n
In Britain, where the first citizen outside of a trial received the coronavirus vaccination on Dec. 8, the FTSE 100 benchmark has outperformed peers in Europe even as its population suffers through a third national lockdown to quell a resurgence of the virus and a new fast-spreading variant. Vaccinations could pave the economy\u2019s path to recovery and further lift the nation\u2019s stocks, according to Herzum.<\/p>\n
\u201cU.K. equities could be in a good position very soon as the U.K. probably reaches herd immunity much faster than the continent due to much better progress on vaccinations,\u201d he said. \u201cThis could result in a big swing in economic activity once Covid-19 related restrictions are lifted.\u201d<\/p>\n